Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Levothyroxine BE [Design Issues]

posted by pjs – India, 2015-07-29 13:32 (3986 d 19:28 ago) – Posting: # 15166
Views: 8,118

Dear all,

We are preparing three strengths of the Levothyroxin sodium oral solution 25 mcg/5ml, 50 mcg/5ml and 100 mcg/5ml for EMA submission.

Any one could provide some reference for the pharmacokinetic linearity of the same.

Also is levothyroxine considered as a NTI?

RMS is UK.

Thanks.
Regards,
PJS

Complete thread:

Levothyroxine formulations drcampos 2007-04-24 04:46
- Levothyroxine BE drcampos 2007-07-19 21:56
  - Levothyroxine BEpjs 2015-07-29 11:32
    - BE of a solution, NTID or not… Helmut 2015-07-29 12:43
      - BE of a solution, NTID or not… pjs 2015-07-29 13:05

Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
325 visitors (0 registered, 325 guests [including 19 identified bots]).
Forum time: 09:01 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks. Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz